AIDS at a

Crossroads

in Canada

A Call For Urgent Action

HIV/AIDS Control is off Track in Canada and Globally in 2025

.01

PHAC reported earlier this year that Canada has seen a 35% increase in HIV new infections between 2022 and 2023. Since then, nearly all regions in Canada are reporting further increases in HIV new infections. Saskatchewan and Manitoba are particularly impacted, as are minorities, priority populations and especially First Nations across the country.

.02

Antiretroviral Therapy (ART) mediated Treatment as Prevention (TasP), a made-in-Canada strategy, combined with Pre-Exposure Prophylaxis (PrEP), can “End HIV/AIDS as an Epidemic” in Canada and globally by 2030. This saves lives, prevents infections, protect societies and saves money.

.03

The Targets to achieve the “End HIV/AIDS as an Epidemic” in Canada and globally by 2030, are also a Canadian innovation, endorsed by the UN and Canada in 2015, and ratified in 2020. These remain in place until 2030.

.04

Recent cuts to domestic and international health programs, primarily (but not exclusively) by the US, have seriously compromised efforts to meet the “End HIV/AIDS as an Epidemic” here and globally by 2030. Indeed, we are already seeing substantial increases in HIV infection among immigrants and refugees.

Fortunately, we have a plan:

Redouble efforts to meet the 95-95-95 Target to achieve the“End HIV/AIDS as an Epidemic” in Canada by 2030

Canada Must Show Leadership for Global Fund’s 8th Replenishment – Organizational Sign-on Letter

Doctors worry about rise in HIV across Canada amid Trump’s funding cuts

- with Stephen Quinn

B.C. experts sound the alarm over rising number of HIV cases

- Gordon McIntyre

The G7’s HIV/AIDS response wanes precisely when global leadership is required

- Julio Montaner
- Providence Health Care
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below